Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
Abstract Severe asthma has a substantial epidemiological impact on children and biological treatments can be an option to take into account, as they target specific molecules and pathways involved in its pathogenesis. Modern medicine is continuously and progressively oriented towards tailored treatm...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2019-11-01
|
| Edice: | Italian Journal of Pediatrics |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s13052-019-0737-4 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|